Intravitreal Tissue Plasminogen Activator Injection for Treatment-Resistant Diabetic Macular Edema of the Vitrectomized Eye

Diabetic macular edema (DME) is the main cause of visual loss in patients with diabetic retinopathy. DME has been treated using intravitreal anti-vascular endothelial growth factor (VEGF) drugs, steroids, laser photocoagulation, vitreoretinal surgery, and their combinations. These modalities are gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Aoki, Ren, Hatano, Makoto, Higashijima, Fumiaki, Yoshimoto, Takuya, Mikuni, Masanori, Ogata, Tadahiko, Kobayashi, Yuka, Wakuta, Makiko, Kimura, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543323/
https://www.ncbi.nlm.nih.gov/pubmed/34720987
http://dx.doi.org/10.1159/000518289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543323/
https://www.ncbi.nlm.nih.gov/pubmed/34720987
http://dx.doi.org/10.1159/000518289

Ejemplares similares